Pei Zhang
Chengdu, 610017, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Author Correction: The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.
Journal: Nature communications
Published: September 24, 2020
Reciprocal REGγ-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma.
Journal: Oncogene
Published: April 26, 2020
Investigating the theragnostic potential of 131I-caerin peptide in thyroid cancer.
Journal: Hellenic journal of nuclear medicine
Published: December 29, 2019
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.
Journal: Nature communications
Published: April 20, 2019
Proteasome-dependent degradation of Smad7 is critical for lung cancer metastasis.
Journal: Cell death and differentiation
Published: April 10, 2019
REGγ ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-β pathway.
Journal: Cell death and differentiation
Published: January 27, 2019
REGγ Controls Hippo Signaling and Reciprocal NF-κB-YAP Regulation to Promote Colon Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 09, 2017
The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis.
Journal: Nature communications
Published: November 27, 2015
Site-specific acetylation of the proteasome activator REGγ directs its heptameric structure and functions.
Journal: The Journal of biological chemistry
Published: April 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026